Skip to Content

ULTRA Duramune DAP + 4L

This page contains information on ULTRA Duramune DAP + 4L for veterinary use.
The information provided typically includes the following:
  • ULTRA Duramune DAP + 4L Indications
  • Warnings and cautions for ULTRA Duramune DAP + 4L
  • Direction and dosage information for ULTRA Duramune DAP + 4L

ULTRA Duramune DAP + 4L

This treatment applies to the following species:
Manufacturer: Elanco US

Canine Distemper-Adenovirus Type 2-Parvovirus Vaccine

Modified Live Virus

Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

For use in animals only

This product has been shown to be effective for the subcutaneous vaccination of healthy dogs 6 weeks of age or older against canine distemper, infectious canine hepatitis, canine adenovirus type 2, canine parvovirus (CPV), Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae and Leptospira pomona. This product contains a CPV 2b strain which has been demonstrated effective against disease caused by CPV 2c in puppies with CPV maternal antibody. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Directions For Use

General directions: Aseptically rehydrate ULTRA Duramune DAP with low volume diluent supplied. Administer one 0.5 mL dose subcutaneously.

Primary vaccination: A recommended vaccination schedule should start at or about 6 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity. Puppies should be revaccinated every 2 to 3 weeks until at least 12 weeks of age.
All dogs over 12 weeks of age should initially receive one dose of this product and a second dose 2 to 3 weeks later.

The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.

ULTRA Duramune DAP + 4L Caution

Store in the dark at 2° to 8°C (35° to 46°F). Avoid freezing. Shake well. In case of anaphylactoid reaction, administer epinephrine. Inactivate all unused contents before disposal. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant animals. In case of human exposure, contact a physician.

Gentamicin and thimerosal added as preservatives.

ULTRA Duramune DAP + 4L Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

Ultra, Duramune, Elanco and the diagonal bar logo are trademarks of Eli Lilly and Company or its affiliates.

© 2017 Elanco US Inc. all rights reserved.

Elanco US Inc., Fort Dodge, IA 50501

Phone: 888-545-5973

VLN/PCN 196/47N9.20

25 Doses

25 Vials of Vaccine plus 25 x 0.5 mL Vials of Diluent

YL101033B

CPN: 1943018.1

ELANCO US INC.
FORT DODGE, IA, 50501
Customer Service:   317-276-1262
Technical Service:   800-428-4441
Website:   www.elanco.us
Email:   elanco@elanco.com
Every effort has been made to ensure the accuracy of the ULTRA Duramune DAP + 4L information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2018 North American Compendiums. Updated: 2018-05-30

Hide